NaD2 (1-7) - NaD1 (8-47)

General Information


DRACP ID  DRACP00611

Peptide Name   NaD2 (1-7) - NaD1 (8-47)

Sequence  RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC

Sequence Length  47

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia 7.9±2.4% Cell death=10µM PI uptake assay 30min 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00611

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys23<--->Cys47; Cys14<---Cys34; Cys20<--->Cys41; Cys24<--->Cys43

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C220H368N68O65S8

Absent amino acids  MVWY

Common amino acids  C

Mass  608291

Pl  8.8

Basic residues  10

Acidic residues  3

Hydrophobic residues  9

Net charge  7

Boman Index  -10365

Hydrophobicity  -40.64

Aliphatic Index  51.91

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  500

Absorbance 280nm  10.87

Polar residues  20

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27503651

Title  Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant

Doi 10.1128/AAC.01479-16

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.